These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3034105)

  • 1. The pattern of train-of-four fade after atracurium: influence of different priming doses.
    Naguib M; Abdulatif M; Gyasi HK; Khawaji Y; Absood GH
    Anesth Analg; 1987 May; 66(5):427-30. PubMed ID: 3034105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming with atracurium: improving intubating conditions with additional doses of thiopental.
    Naguib M; Abdulatif M; Gyasi HK; Absood GH
    Anesth Analg; 1986 Dec; 65(12):1295-9. PubMed ID: 3777460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Train-of-four ratio after antagonism of atracurium with edrophonium: influence of different priming doses of edrophonium.
    Naguib M
    Can J Anaesth; 1989 Jan; 36(1):25-9. PubMed ID: 2644050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preanesthetic train-of-four fade predicts the atracurium requirement of myasthenia gravis patients.
    Mann R; Blobner M; Jelen-Esselborn S; Busley R; Werner C
    Anesthesiology; 2000 Aug; 93(2):346-50. PubMed ID: 10910480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
    Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C
    Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The optimal priming dose for atracurium.
    Naguib M; Abdullatif M; Absood GH
    Can Anaesth Soc J; 1986 Jul; 33(4):453-7. PubMed ID: 3755641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting train-of-four fade.
    Pearce AC; Casson WR; Jones RM
    Br J Anaesth; 1985 Jun; 57(6):602-6. PubMed ID: 2860913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of atracurium-induced block in obese patients.
    Kirkegaard-Nielsen H; Lindholm P; Petersen HS; Severinsen IK
    Can J Anaesth; 1998 Jan; 45(1):39-41. PubMed ID: 9466025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of intense neuromuscular blockade following infusion of atracurium.
    Engbaek J; Ostergaard D; Skovgaard LT; Viby-Mogensen J
    Anesthesiology; 1990 May; 72(5):803-6. PubMed ID: 2160206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twitch augmentation and train-of-four fade during onset of neuromuscular block after subclinical doses of suxamethonium.
    Kim SY; Lee JS; Kim SC; Park W
    Br J Anaesth; 1997 Sep; 79(3):379-81. PubMed ID: 9389859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular sensitivity to atracurium in humans.
    Torda TA; Graham GG; Tsui D
    Anaesth Intensive Care; 1990 Feb; 18(1):62-8. PubMed ID: 2159734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the train-of-four fade profiles produced by vecuronium and atracurium.
    Fletcher JE; Sebel PS; Mick SA; Van Duys J; Ryan K
    Br J Anaesth; 1992 Feb; 68(2):207-8. PubMed ID: 1347231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atracurium in the myasthenic patient.
    Bell CF; Florence AM; Hunter JM; Jones RS; Utting JE
    Anaesthesia; 1984 Oct; 39(10):961-8. PubMed ID: 6093617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of vecuronium, atracurium and pancuronium in divided doses: effect on onset and duration of action.
    Brady MM; Mirakhur RK; Clarke RS
    Eur J Anaesthesiol; 1988 Jul; 5(4):243-9. PubMed ID: 2904367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical recovery and train-of-four ratio measured mechanically and electromyographically following atracurium.
    Engbaek J; Ostergaard D; Viby-Mogensen J; Skovgaard LT
    Anesthesiology; 1989 Sep; 71(3):391-5. PubMed ID: 2549818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment with atracurium: the influence on neuromuscular transmission and pulmonary function.
    Howardy-Hansen P; Møller J; Hansen B
    Acta Anaesthesiol Scand; 1987 Oct; 31(7):642-4. PubMed ID: 2825462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the onset time, duration of action, and fade characteristics of atracurium and vecuronium.
    Haines M
    AANA J; 1993 Dec; 61(6):592-6. PubMed ID: 7903505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nondepolarizing neuromuscular blocking drugs and train-of-four fade.
    McCoy EP; Connolly FM; Mirakhur RK; Loan PB; Paxton LD
    Can J Anaesth; 1995 Mar; 42(3):213-6. PubMed ID: 7743572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block.
    Whalley DG; Lewis B; Bedocs NM
    Can J Anaesth; 1994 Jan; 41(1):31-5. PubMed ID: 8111941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
    Naguib M; Riad W
    Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.